Global Repurposed Drugs Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Repurposed Drugs market size was valued at US$ 14930 million in 2023. With growing demand in downstream market, the Repurposed Drugs is forecast to a readjusted size of US$ 26710 million by 2030 with a CAGR of 8.7% during review period.
The research report highlights the growth potential of the global Repurposed Drugs market. Repurposed Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Repurposed Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Repurposed Drugs market.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Repurposed Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Repurposed Drugs market. It may include historical data, market segmentation by Type (e.g., Generic Drugs, Clinical Trial Failed Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Repurposed Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Repurposed Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Repurposed Drugs industry. This include advancements in Repurposed Drugs technology, Repurposed Drugs new entrants, Repurposed Drugs new investment, and other innovations that are shaping the future of Repurposed Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Repurposed Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Repurposed Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Repurposed Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Repurposed Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Repurposed Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Repurposed Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Repurposed Drugs market.
Market Segmentation:
Repurposed Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Repurposed Drugs market size was valued at US$ 14930 million in 2023. With growing demand in downstream market, the Repurposed Drugs is forecast to a readjusted size of US$ 26710 million by 2030 with a CAGR of 8.7% during review period.
The research report highlights the growth potential of the global Repurposed Drugs market. Repurposed Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Repurposed Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Repurposed Drugs market.
Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Repurposed Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Repurposed Drugs market. It may include historical data, market segmentation by Type (e.g., Generic Drugs, Clinical Trial Failed Drugs), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Repurposed Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Repurposed Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Repurposed Drugs industry. This include advancements in Repurposed Drugs technology, Repurposed Drugs new entrants, Repurposed Drugs new investment, and other innovations that are shaping the future of Repurposed Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Repurposed Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Repurposed Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Repurposed Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Repurposed Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Repurposed Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Repurposed Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Repurposed Drugs market.
Market Segmentation:
Repurposed Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Generic Drugs
- Clinical Trial Failed Drugs
- Cardiovascular Diseases
- Mental Illness
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Novartis
- Mylan
- Johnson & Johnson
- Pfizer
- Bausch Health
- GSK
- ChemRar Group
- Glenmark
- Fujifilm
- Dr. Reddy
- R-Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Repurposed Drugs Market Size 2019-2030
2.1.2 Repurposed Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Repurposed Drugs Segment by Type
2.2.1 Generic Drugs
2.2.2 Clinical Trial Failed Drugs
2.3 Repurposed Drugs Market Size by Type
2.3.1 Repurposed Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Repurposed Drugs Market Size Market Share by Type (2019-2024)
2.4 Repurposed Drugs Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Mental Illness
2.4.3 Cancer
2.4.4 Other
2.5 Repurposed Drugs Market Size by Application
2.5.1 Repurposed Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Repurposed Drugs Market Size Market Share by Application (2019-2024)
3 REPURPOSED DRUGS MARKET SIZE BY PLAYER
3.1 Repurposed Drugs Market Size Market Share by Players
3.1.1 Global Repurposed Drugs Revenue by Players (2019-2024)
3.1.2 Global Repurposed Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Repurposed Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 REPURPOSED DRUGS BY REGIONS
4.1 Repurposed Drugs Market Size by Regions (2019-2024)
4.2 Americas Repurposed Drugs Market Size Growth (2019-2024)
4.3 APAC Repurposed Drugs Market Size Growth (2019-2024)
4.4 Europe Repurposed Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Repurposed Drugs Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Repurposed Drugs Market Size by Country (2019-2024)
5.2 Americas Repurposed Drugs Market Size by Type (2019-2024)
5.3 Americas Repurposed Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Repurposed Drugs Market Size by Region (2019-2024)
6.2 APAC Repurposed Drugs Market Size by Type (2019-2024)
6.3 APAC Repurposed Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Repurposed Drugs by Country (2019-2024)
7.2 Europe Repurposed Drugs Market Size by Type (2019-2024)
7.3 Europe Repurposed Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Repurposed Drugs by Region (2019-2024)
8.2 Middle East & Africa Repurposed Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Repurposed Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL REPURPOSED DRUGS MARKET FORECAST
10.1 Global Repurposed Drugs Forecast by Regions (2025-2030)
10.1.1 Global Repurposed Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Repurposed Drugs Forecast
10.1.3 APAC Repurposed Drugs Forecast
10.1.4 Europe Repurposed Drugs Forecast
10.1.5 Middle East & Africa Repurposed Drugs Forecast
10.2 Americas Repurposed Drugs Forecast by Country (2025-2030)
10.2.1 United States Repurposed Drugs Market Forecast
10.2.2 Canada Repurposed Drugs Market Forecast
10.2.3 Mexico Repurposed Drugs Market Forecast
10.2.4 Brazil Repurposed Drugs Market Forecast
10.3 APAC Repurposed Drugs Forecast by Region (2025-2030)
10.3.1 China Repurposed Drugs Market Forecast
10.3.2 Japan Repurposed Drugs Market Forecast
10.3.3 Korea Repurposed Drugs Market Forecast
10.3.4 Southeast Asia Repurposed Drugs Market Forecast
10.3.5 India Repurposed Drugs Market Forecast
10.3.6 Australia Repurposed Drugs Market Forecast
10.4 Europe Repurposed Drugs Forecast by Country (2025-2030)
10.4.1 Germany Repurposed Drugs Market Forecast
10.4.2 France Repurposed Drugs Market Forecast
10.4.3 UK Repurposed Drugs Market Forecast
10.4.4 Italy Repurposed Drugs Market Forecast
10.4.5 Russia Repurposed Drugs Market Forecast
10.5 Middle East & Africa Repurposed Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Repurposed Drugs Market Forecast
10.5.2 South Africa Repurposed Drugs Market Forecast
10.5.3 Israel Repurposed Drugs Market Forecast
10.5.4 Turkey Repurposed Drugs Market Forecast
10.5.5 GCC Countries Repurposed Drugs Market Forecast
10.6 Global Repurposed Drugs Forecast by Type (2025-2030)
10.7 Global Repurposed Drugs Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Repurposed Drugs Product Offered
11.1.3 Teva Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Repurposed Drugs Product Offered
11.2.3 Novartis Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Repurposed Drugs Product Offered
11.3.3 Mylan Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Repurposed Drugs Product Offered
11.4.3 Johnson & Johnson Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Repurposed Drugs Product Offered
11.5.3 Pfizer Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Information
11.6.2 Bausch Health Repurposed Drugs Product Offered
11.6.3 Bausch Health Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bausch Health Main Business Overview
11.6.5 Bausch Health Latest Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Repurposed Drugs Product Offered
11.7.3 GSK Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 GSK Main Business Overview
11.7.5 GSK Latest Developments
11.8 ChemRar Group
11.8.1 ChemRar Group Company Information
11.8.2 ChemRar Group Repurposed Drugs Product Offered
11.8.3 ChemRar Group Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ChemRar Group Main Business Overview
11.8.5 ChemRar Group Latest Developments
11.9 Glenmark
11.9.1 Glenmark Company Information
11.9.2 Glenmark Repurposed Drugs Product Offered
11.9.3 Glenmark Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Glenmark Main Business Overview
11.9.5 Glenmark Latest Developments
11.10 Fujifilm
11.10.1 Fujifilm Company Information
11.10.2 Fujifilm Repurposed Drugs Product Offered
11.10.3 Fujifilm Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fujifilm Main Business Overview
11.10.5 Fujifilm Latest Developments
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Information
11.11.2 Dr. Reddy Repurposed Drugs Product Offered
11.11.3 Dr. Reddy Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Dr. Reddy Main Business Overview
11.11.5 Dr. Reddy Latest Developments
11.12 R-Pharma
11.12.1 R-Pharma Company Information
11.12.2 R-Pharma Repurposed Drugs Product Offered
11.12.3 R-Pharma Repurposed Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 R-Pharma Main Business Overview
11.12.5 R-Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Repurposed Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Generic Drugs
Table 3. Major Players of Clinical Trial Failed Drugs
Table 4. Repurposed Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 7. Repurposed Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 10. Global Repurposed Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Repurposed Drugs Revenue Market Share by Player (2019-2024)
Table 12. Repurposed Drugs Key Players Head office and Products Offered
Table 13. Repurposed Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Repurposed Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Repurposed Drugs Market Size Market Share by Regions (2019-2024)
Table 18. Global Repurposed Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Repurposed Drugs Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Repurposed Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Repurposed Drugs Market Size Market Share by Country (2019-2024)
Table 22. Americas Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 24. Americas Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 26. APAC Repurposed Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Repurposed Drugs Market Size Market Share by Region (2019-2024)
Table 28. APAC Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 30. APAC Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 32. Europe Repurposed Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Repurposed Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 36. Europe Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Repurposed Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Repurposed Drugs Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Repurposed Drugs
Table 45. Key Market Challenges & Risks of Repurposed Drugs
Table 46. Key Industry Trends of Repurposed Drugs
Table 47. Global Repurposed Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Repurposed Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Repurposed Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Repurposed Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Teva Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 52. Teva Repurposed Drugs Product Offered
Table 53. Teva Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Teva Main Business
Table 55. Teva Latest Developments
Table 56. Novartis Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 57. Novartis Repurposed Drugs Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Mylan Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 62. Mylan Repurposed Drugs Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Mylan Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 67. Johnson & Johnson Repurposed Drugs Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Johnson & Johnson Latest Developments
Table 71. Pfizer Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 72. Pfizer Repurposed Drugs Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Latest Developments
Table 76. Bausch Health Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 77. Bausch Health Repurposed Drugs Product Offered
Table 78. Bausch Health Main Business
Table 79. Bausch Health Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bausch Health Latest Developments
Table 81. GSK Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 82. GSK Repurposed Drugs Product Offered
Table 83. GSK Main Business
Table 84. GSK Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. GSK Latest Developments
Table 86. ChemRar Group Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 87. ChemRar Group Repurposed Drugs Product Offered
Table 88. ChemRar Group Main Business
Table 89. ChemRar Group Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ChemRar Group Latest Developments
Table 91. Glenmark Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 92. Glenmark Repurposed Drugs Product Offered
Table 93. Glenmark Main Business
Table 94. Glenmark Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Glenmark Latest Developments
Table 96. Fujifilm Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 97. Fujifilm Repurposed Drugs Product Offered
Table 98. Fujifilm Main Business
Table 99. Fujifilm Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Fujifilm Latest Developments
Table 101. Dr. Reddy Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 102. Dr. Reddy Repurposed Drugs Product Offered
Table 103. Dr. Reddy Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Dr. Reddy Main Business
Table 105. Dr. Reddy Latest Developments
Table 106. R-Pharma Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 107. R-Pharma Repurposed Drugs Product Offered
Table 108. R-Pharma Main Business
Table 109. R-Pharma Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. R-Pharma Latest Developments
Table 1. Repurposed Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Generic Drugs
Table 3. Major Players of Clinical Trial Failed Drugs
Table 4. Repurposed Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 7. Repurposed Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 10. Global Repurposed Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Repurposed Drugs Revenue Market Share by Player (2019-2024)
Table 12. Repurposed Drugs Key Players Head office and Products Offered
Table 13. Repurposed Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Repurposed Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Repurposed Drugs Market Size Market Share by Regions (2019-2024)
Table 18. Global Repurposed Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Repurposed Drugs Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Repurposed Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Repurposed Drugs Market Size Market Share by Country (2019-2024)
Table 22. Americas Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 24. Americas Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 26. APAC Repurposed Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Repurposed Drugs Market Size Market Share by Region (2019-2024)
Table 28. APAC Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 30. APAC Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 32. Europe Repurposed Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Repurposed Drugs Market Size Market Share by Country (2019-2024)
Table 34. Europe Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 36. Europe Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Repurposed Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Repurposed Drugs Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Repurposed Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Repurposed Drugs Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Repurposed Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Repurposed Drugs Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Repurposed Drugs
Table 45. Key Market Challenges & Risks of Repurposed Drugs
Table 46. Key Industry Trends of Repurposed Drugs
Table 47. Global Repurposed Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Repurposed Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Repurposed Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Repurposed Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Teva Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 52. Teva Repurposed Drugs Product Offered
Table 53. Teva Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Teva Main Business
Table 55. Teva Latest Developments
Table 56. Novartis Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 57. Novartis Repurposed Drugs Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Mylan Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 62. Mylan Repurposed Drugs Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Mylan Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 67. Johnson & Johnson Repurposed Drugs Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Johnson & Johnson Latest Developments
Table 71. Pfizer Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 72. Pfizer Repurposed Drugs Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Latest Developments
Table 76. Bausch Health Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 77. Bausch Health Repurposed Drugs Product Offered
Table 78. Bausch Health Main Business
Table 79. Bausch Health Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Bausch Health Latest Developments
Table 81. GSK Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 82. GSK Repurposed Drugs Product Offered
Table 83. GSK Main Business
Table 84. GSK Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. GSK Latest Developments
Table 86. ChemRar Group Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 87. ChemRar Group Repurposed Drugs Product Offered
Table 88. ChemRar Group Main Business
Table 89. ChemRar Group Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. ChemRar Group Latest Developments
Table 91. Glenmark Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 92. Glenmark Repurposed Drugs Product Offered
Table 93. Glenmark Main Business
Table 94. Glenmark Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Glenmark Latest Developments
Table 96. Fujifilm Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 97. Fujifilm Repurposed Drugs Product Offered
Table 98. Fujifilm Main Business
Table 99. Fujifilm Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Fujifilm Latest Developments
Table 101. Dr. Reddy Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 102. Dr. Reddy Repurposed Drugs Product Offered
Table 103. Dr. Reddy Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Dr. Reddy Main Business
Table 105. Dr. Reddy Latest Developments
Table 106. R-Pharma Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 107. R-Pharma Repurposed Drugs Product Offered
Table 108. R-Pharma Main Business
Table 109. R-Pharma Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. R-Pharma Latest Developments
LIST OF FIGURES
Figure 1. Repurposed Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Repurposed Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Repurposed Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Repurposed Drugs Sales Market Share by Country/Region (2023)
Figure 8. Repurposed Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Repurposed Drugs Market Size Market Share by Type in 2023
Figure 10. Repurposed Drugs in Cardiovascular Diseases
Figure 11. Global Repurposed Drugs Market: Cardiovascular Diseases (2019-2024) & ($ Millions)
Figure 12. Repurposed Drugs in Mental Illness
Figure 13. Global Repurposed Drugs Market: Mental Illness (2019-2024) & ($ Millions)
Figure 14. Repurposed Drugs in Cancer
Figure 15. Global Repurposed Drugs Market: Cancer (2019-2024) & ($ Millions)
Figure 16. Repurposed Drugs in Other
Figure 17. Global Repurposed Drugs Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Repurposed Drugs Market Size Market Share by Application in 2023
Figure 19. Global Repurposed Drugs Revenue Market Share by Player in 2023
Figure 20. Global Repurposed Drugs Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 22. APAC Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Europe Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 25. Americas Repurposed Drugs Value Market Share by Country in 2023
Figure 26. United States Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Repurposed Drugs Market Size Market Share by Region in 2023
Figure 31. APAC Repurposed Drugs Market Size Market Share by Type in 2023
Figure 32. APAC Repurposed Drugs Market Size Market Share by Application in 2023
Figure 33. China Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Repurposed Drugs Market Size Market Share by Country in 2023
Figure 40. Europe Repurposed Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe Repurposed Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Repurposed Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Repurposed Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Repurposed Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 56. APAC Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 57. Europe Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 59. United States Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Canada Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 63. China Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Japan Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 65. Korea Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 67. India Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Australia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 69. Germany Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 70. France Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 71. UK Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Italy Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Russia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 74. Spain Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 77. Israel Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 80. Global Repurposed Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Repurposed Drugs Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Repurposed Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Repurposed Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Repurposed Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Repurposed Drugs Sales Market Share by Country/Region (2023)
Figure 8. Repurposed Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Repurposed Drugs Market Size Market Share by Type in 2023
Figure 10. Repurposed Drugs in Cardiovascular Diseases
Figure 11. Global Repurposed Drugs Market: Cardiovascular Diseases (2019-2024) & ($ Millions)
Figure 12. Repurposed Drugs in Mental Illness
Figure 13. Global Repurposed Drugs Market: Mental Illness (2019-2024) & ($ Millions)
Figure 14. Repurposed Drugs in Cancer
Figure 15. Global Repurposed Drugs Market: Cancer (2019-2024) & ($ Millions)
Figure 16. Repurposed Drugs in Other
Figure 17. Global Repurposed Drugs Market: Other (2019-2024) & ($ Millions)
Figure 18. Global Repurposed Drugs Market Size Market Share by Application in 2023
Figure 19. Global Repurposed Drugs Revenue Market Share by Player in 2023
Figure 20. Global Repurposed Drugs Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 22. APAC Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 23. Europe Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Repurposed Drugs Market Size 2019-2024 ($ Millions)
Figure 25. Americas Repurposed Drugs Value Market Share by Country in 2023
Figure 26. United States Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Repurposed Drugs Market Size Market Share by Region in 2023
Figure 31. APAC Repurposed Drugs Market Size Market Share by Type in 2023
Figure 32. APAC Repurposed Drugs Market Size Market Share by Application in 2023
Figure 33. China Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Repurposed Drugs Market Size Market Share by Country in 2023
Figure 40. Europe Repurposed Drugs Market Size Market Share by Type (2019-2024)
Figure 41. Europe Repurposed Drugs Market Size Market Share by Application (2019-2024)
Figure 42. Germany Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Repurposed Drugs Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Repurposed Drugs Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Repurposed Drugs Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Repurposed Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 56. APAC Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 57. Europe Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 59. United States Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 60. Canada Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 63. China Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Japan Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 65. Korea Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 67. India Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Australia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 69. Germany Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 70. France Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 71. UK Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Italy Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Russia Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 74. Spain Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 77. Israel Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Repurposed Drugs Market Size 2025-2030 ($ Millions)
Figure 80. Global Repurposed Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Repurposed Drugs Market Size Market Share Forecast by Application (2025-2030)
More Publications
Global Interlock Vials Market Growth 2023-2029
US$ 3,660.00
March 2023
93 pages
Global Orthopedic Reconstruction in Knee & Hip Market Growth 2025-2031
US$ 3,660.00
April 2025
93 pages
Global Track-etched Membrane Market Growth 2025-2031
US$ 3,660.00
January 2025
125 pages
Global Serotonin Supplement Market Growth 2025-2031
US$ 3,660.00
February 2025
104 pages
